SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-018125
Filing Date
2023-11-08
Accepted
2023-11-08 08:30:12
Documents
15
Period of Report
2023-11-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20231105x8k.htm   iXBRL 8-K 46518
2 EX-99.1 hrmy-20231105xex99d1.htm EX-99.1 13184
3 GRAPHIC hrmy-20231105x8k001.jpg GRAPHIC 1167
4 GRAPHIC hrmy-20231105xex99d1001.jpg GRAPHIC 9992
  Complete submission text file 0001558370-23-018125.txt   202378

Data Files

Seq Description Document Type Size
5 EX-101.SCH hrmy-20231105.xsd EX-101.SCH 3163
6 EX-101.LAB hrmy-20231105_lab.xml EX-101.LAB 15928
7 EX-101.PRE hrmy-20231105_pre.xml EX-101.PRE 10081
9 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20231105x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 231386111
SIC: 2834 Pharmaceutical Preparations